Juniper Pharmaceuticals Reports Results from Phase 2b Clinical Trial of COL-1077 Lidocaine Vaginal Gel in Gynecologic Procedure Pain
BOSTON, Aug. 17, 2016 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ( " Juniper " or the " Company " ), a women ' s health therapeutics company, today announced that a recently completed Phase 2b clinical trial evaluating its 10% lidocaine... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 17, 2016 Category: Pharmaceuticals Source Type: clinical trials
Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
Condition: Bacterial VaginosisInterventions: Drug: 5% Monolaurin Vaginal Gel; Other: PlaceboSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2016 Category: Research Source Type: clinical trials
